{
    "nctId": "NCT01476111",
    "briefTitle": "Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer",
    "officialTitle": "A Prospective, Exploratory Observational Study Evaluating Specific Biomarkers in Primary Invasive Breast Cancer and Their Modulation by Standard Neoadjuvant Therapy",
    "overallStatus": "TERMINATED",
    "conditions": "Neoplasms, Breast",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 117,
    "primaryOutcomeMeasure": "The presence of a specific predictive gene expression signature in tumor tissues",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* The patient has 18 years of age or older at the time of consent.\n* The patient has provided pre-treatment tumor samples for WT1 expression screening and gene expression profiling in the context of the NCT01220128 study.\n* The patient has a histologically or cytologically confirmed primary invasive breast cancer.\n* The patient has provided written informed consent before any new information or new material is provided to the Sponsor.\n* The patient is planned to receive, is receiving or has received standard and/or investigational therapy for breast cancer.\n* The patient is planned to receive, is receiving or has received standard and/or investigational therapy for breast cancer.\n\nExclusion Criteria:\n\nNot applicable.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}